
Medical Affairs Outsourcing Market by Services (Clinical Trial Applications & Product Registrations, Regulatory Consulting & Legal Representation, Regulatory Writing & Publishing), End-User (Biotechnology Companies, Mid- Sized Pharmaceutical Companies) -
Description
Medical Affairs Outsourcing Market by Services (Clinical Trial Applications & Product Registrations, Regulatory Consulting & Legal Representation, Regulatory Writing & Publishing), End-User (Biotechnology Companies, Mid- Sized Pharmaceutical Companies) - Global Forecast 2023-2030
The Medical Affairs Outsourcing Market size was estimated at USD 7.98 billion in 2022 and expected to reach USD 9.03 billion in 2023, at a CAGR 13.22% to reach USD 21.58 billion by 2030.
Market Segmentation & Coverage:
This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Medical Affairs Outsourcing Market.
- Based on Services, market is studied across Clinical Trial Applications & Product Registrations, Regulatory Consulting & Legal Representation, and Regulatory Writing & Publishing. The Regulatory Consulting & Legal Representation is projected to witness significant market share during forecast period.
- Based on End-User, market is studied across Biotechnology Companies and Mid- Sized Pharmaceutical Companies. The Biotechnology Companies is projected to witness significant market share during forecast period.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix is an indispensable tool for assessing the Medical Affairs Outsourcing Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.
Market Share Analysis:
The Market Share Analysis offers invaluable insights into the vendor landscape Medical Affairs Outsourcing Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.
Key Company Profiles:
The report delves into recent significant developments in the Medical Affairs Outsourcing Market, highlighting leading vendors and their innovative profiles. These include Accell Clinical Research, LLC, Charles River Laboratories International, Inc., Clinilabs, Inc., Covance, Inc., Criterium, Inc., Genpact Ltd, ICON plc, Indegene, Inc., Medpace, Inc., Parexel International Corporation, Pharmaceutical Product Development, LLC, PRA Health Sciences, Inc., Promedica International, Syneos Health, Inc., and WuXi AppTec Co., Ltd.
The report offers valuable insights on the following aspects:
- Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
- Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
- Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
- Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
- Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast for the Medical Affairs Outsourcing Market?
- Which products, segments, applications, and areas hold the highest investment potential in the Medical Affairs Outsourcing Market?
- What is the competitive strategic window for identifying opportunities in the Medical Affairs Outsourcing Market?
- What are the latest technology trends and regulatory frameworks in the Medical Affairs Outsourcing Market?
- What is the market share of the leading vendors in the Medical Affairs Outsourcing Market?
- Which modes and strategic moves are suitable for entering the Medical Affairs Outsourcing Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
190 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Medical Affairs Outsourcing Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing adoption of cost-saving measures with changing reimbursement policies in pharmaceutical sector
- 5.1.1.2. Potential demand attributed to high cost involved in training and R&D process
- 5.1.1.3. Availability of price-efficient solutions and compliance with regulatory protocols
- 5.1.2. Restraints
- 5.1.2.1. High cost involved in R&D of the pharmaceutical sector
- 5.1.3. Opportunities
- 5.1.3.1. Ongoing focus on core activities such as drug development in pharmaceutical companies
- 5.1.3.2. Surge in outsourcing of medical affairs such as medical material, field based medical teams and medical publications
- 5.1.4. Challenges
- 5.1.4.1. Concerns over data breaches and security
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of COVID-19
- 5.5. Cumulative Impact of Russia-Ukraine Conflict
- 5.6. Cumulative Impact of High Inflation
- 5.7. Porter’s Five Forces Analysis
- 5.7.1. Threat of New Entrants
- 5.7.2. Threat of Substitutes
- 5.7.3. Bargaining Power of Customers
- 5.7.4. Bargaining Power of Suppliers
- 5.7.5. Industry Rivalry
- 5.8. Value Chain & Critical Path Analysis
- 5.9. Regulatory Framework
- 5.10. Client Customization
- 6. Medical Affairs Outsourcing Market, by Services
- 6.1. Introduction
- 6.2. Clinical Trial Applications & Product Registrations
- 6.3. Regulatory Consulting & Legal Representation
- 6.4. Regulatory Writing & Publishing
- 7. Medical Affairs Outsourcing Market, by End-User
- 7.1. Introduction
- 7.2. Biotechnology Companies
- 7.3. Mid- Sized Pharmaceutical Companies
- 8. Americas Medical Affairs Outsourcing Market
- 8.1. Introduction
- 8.2. Argentina
- 8.3. Brazil
- 8.4. Canada
- 8.5. Mexico
- 8.6. United States
- 9. Asia-Pacific Medical Affairs Outsourcing Market
- 9.1. Introduction
- 9.2. Australia
- 9.3. China
- 9.4. India
- 9.5. Indonesia
- 9.6. Japan
- 9.7. Malaysia
- 9.8. Philippines
- 9.9. Singapore
- 9.10. South Korea
- 9.11. Taiwan
- 9.12. Thailand
- 9.13. Vietnam
- 10. Europe, Middle East & Africa Medical Affairs Outsourcing Market
- 10.1. Introduction
- 10.2. Denmark
- 10.3. Egypt
- 10.4. Finland
- 10.5. France
- 10.6. Germany
- 10.7. Israel
- 10.8. Italy
- 10.9. Netherlands
- 10.10. Nigeria
- 10.11. Norway
- 10.12. Poland
- 10.13. Qatar
- 10.14. Russia
- 10.15. Saudi Arabia
- 10.16. South Africa
- 10.17. Spain
- 10.18. Sweden
- 10.19. Switzerland
- 10.20. Turkey
- 10.21. United Arab Emirates
- 10.22. United Kingdom
- 11. Competitive Landscape
- 11.1. FPNV Positioning Matrix
- 11.2. Market Share Analysis, By Key Player
- 11.3. Competitive Scenario Analysis, By Key Player
- 12. Competitive Portfolio
- 12.1. Key Company Profiles
- 12.1.1. Accell Clinical Research, LLC
- 12.1.2. Charles River Laboratories International, Inc.
- 12.1.3. Clinilabs, Inc.
- 12.1.4. Covance, Inc.
- 12.1.5. Criterium, Inc.
- 12.1.6. Genpact Ltd
- 12.1.7. ICON plc
- 12.1.8. Indegene, Inc.
- 12.1.9. Medpace, Inc.
- 12.1.10. Parexel International Corporation
- 12.1.11. Pharmaceutical Product Development, LLC
- 12.1.12. PRA Health Sciences, Inc.
- 12.1.13. Promedica International
- 12.1.14. Syneos Health, Inc.
- 12.1.15. WuXi AppTec Co., Ltd
- 12.2. Key Product Portfolio
- 13. Appendix
- 13.1. Discussion Guide
- 13.2. License & Pricing
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.